Levosert Shi (Levonorgestrel)

Levonorgestrel released from the device binds to progesterone receptors, suppressing ovulation, thickening cervical mucus to block sperm, and inducing endometrial atrophy. These combined actions create a uterine environment that prevents implantation and reduces menstrual blood loss.

Levosert Shi is supplied as a pre‑loaded intrauterine system that releases a fixed amount of levonorgestrel over several years. The exact dosing regimen is determined by the prescribing clinician based on the product’s specifications and the patient’s needs.

Levosert Shi is contraindicated in women who are pregnant; it must be inserted only after confirming a negative pregnancy test. Limited data exist for use while breastfeeding, so clinicians should evaluate the risk‑benefit profile and discuss alternatives with the patient.

To order Levosert Shi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with oral progestin pills, Levosert Shi offers continuous, low‑dose hormone delivery without daily adherence. Unlike copper IUDs, it provides hormonal benefits such as reduced menstrual bleeding. Its efficacy, duration (up to several years), and localized action make it a convenient long‑acting reversible contraceptive option.

Levosert Shi should be stored at room temperature, ideally below 25 °C. Keep the device in its original sterile packaging, protect it from moisture, direct sunlight and extreme temperatures until the time of insertion by a qualified healthcare professional.

A trained clinician inserts Levosert Shi through the cervical canal into the uterine cavity using a specialized inserter. The procedure is performed in a clinical setting under aseptic conditions, and the device remains in place to release levonorgestrel for the approved duration.

Serious risks include uterine perforation during insertion, device expulsion or displacement, ectopic pregnancy if contraception fails, and severe allergic reactions such as anaphylaxis. Patients should be monitored for these events and instructed to seek immediate medical attention if symptoms arise.

Levosert Shi is not suitable for women with active pelvic infection, known hypersensitivity to levonorgestrel, uterine anomalies that prevent proper placement, current or suspected pregnancy, or a history of uterine or breast cancer. A thorough medical assessment is required before insertion.